Abstract

OBJecTIVe: The Turkish Society of Nephrology registry collects data on hemodialysis, peritoneal dialysis and transplantation on an annual basis. Registry reports are printed every year as a booklet and this is the 25th year of registry reports. The registry is in close collaboration with international registries. MATeRIAL and MeThODS: In this paper, data from the 2014 registry report are summarized and additionally yearly trends in the management of end-stage renal disease are also provided. ReSULTS: The number of patients on renal replacement therapy is increasing. At the end of 2014, 71.318 patients were on renal replacement therapy. The prevalence and incidence of end-stage renal disease was 918 and 147 per million population respectively. Diabetes was the most important cause of end-stage renal disease. Hemodialysis (78.4%) was the most common type of treatment modality, followed by transplantation (15.6%) and peritoneal dialysis (6.0%). cONcLUSION: End-stage kidney disease is a very important and growing health problem for our country. The renal registry is a leading tool for providing current and sound data on this public health problem. key wORDS: Kidney failure, Renal replacement therapy, Hemodialysis, Peritoneal dialysis, Renal transplantation, Registry Nurhan SeyAhi1 kenan ATes2 Gultekin SuLeyMANLAR3 1 Istanbul Universitesi, Cerrahpasa Tip Fakultesi, Ic Hastaliklari Anabilim Dali, Nefroloji Bilim Dali, Istanbul, Turkiye 2 Ankara Universitesi, Ankara Tip Fakultesi, Ic Hastaliklari Anabilim Dali, Nefroloji Bilim Dali, Ankara, Turkiye 3 Akdeniz Universitesi, Akdeniz Tip Fakultesi, Ic Hastaliklari Anabilim Dali, Nefroloji Bilim Dali, Antalya, Turkiye

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.